Protagonist Therapeutics is a clinical-stage biopharmaceutical company with multiple peptide-based new chemical entities in different stages of development. Discovered through our proprietary technology platform, our differentiated assets are designed to impact key biological targets and pathways, providing the potential to add new indications and expand our pipeline efficiently. Our work spans across rare disease and large-market opportunities where there is significant unmet medical need.